In this study, we identified an infrequent functional variant (rs28385692) in IL22RA2, which confers risk to MS independently of the major GWAS-derived signal, and we were able to show that this variant has immediate functional effects by reducing secreted IL-22BP levels in transfected HEK293 cells. The gene discussed is IL22RA2; the disease is myeloid sarcoma.